Amarin Corporation plc (ADR)
General ticker "AMRN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $5.3B (TTM average)
Amarin Corporation plc (ADR) follows the US Stock Market performance with the rate: 56.9%.
Estimated limits based on current volatility of 2.3%: low 15.43$, high 16.16$
Factors to consider:
- Total employees count: 275 (0.0%) as of 2024
- US accounted for 72.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on VASCEPA, Regulatory and compliance, Economic downturns and volatility, Labor/talent shortage/retention, Supply chain disruptions
- Current price 17.7% above estimated high
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.21$, 13.99$]
- 2025-12-31 to 2026-12-31 estimated range: [4.62$, 12.32$]
Financial Metrics affecting the AMRN estimates:
- Negative: with PPE of -2.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.83 <= 0.33
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 70.94 > 63.39
- Negative: negative Industry operating cash flow (median)
Short-term AMRN quotes
Long-term AMRN plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $369.19MM | $306.91MM | $228.61MM |
| Operating Expenses | $475.06MM | $374.50MM | $320.41MM |
| Operating Income | $-105.87MM | $-67.59MM | $-91.80MM |
| Non-Operating Income | $2.06MM | $13.92MM | $14.60MM |
| Interest Expense | $0.01MM | $0.01MM | $0.01MM |
| R&D Expense | $30.41MM | $22.22MM | $20.87MM |
| Income(Loss) | $-103.81MM | $-53.67MM | $-77.20MM |
| Taxes | $2.00MM | $5.44MM | $4.98MM |
| Profit(Loss)* | $-105.87MM | $-58.88MM | $-82.18MM |
| Stockholders Equity | $595.33MM | $552.10MM | $486.18MM |
| Inventory | $228.73MM | $258.62MM | $166.05MM |
| Assets | $886.18MM | $831.68MM | $685.35MM |
| Operating Cash Flow | $-180.09MM | $6.88MM | $-31.02MM |
| Capital expenditure | $0.00MM | $0.02MM | $0.00MM |
| Investing Cash Flow | $175.29MM | $-25.52MM | $-45.98MM |
| Financing Cash Flow | $-0.38MM | $0.23MM | $-1.44MM |
| Earnings Per Share** | $-0.26 | $-0.15 | $-0.20 |
| Ordinary share to ADR | 0.05x | 0.05x | 0.05x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.